Vector delivery-dependant effect of human tissue plasminogen activator signal peptide on vaccine induction of T cells by Hanke, T, Ondondo, B, Abdul-Jawad, S, Roshorm, Y, Bridgeman, A

T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load. by Roshorm, Y, Cottingham, MG, Potash, M, Volsky, D, Hanke, T

Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge. by Roshorm, Y, Hong, J, Kobayashi, N, Mcmichael, A, Volsky, D, Potash, M, Takiguchi, M, Hanke, T

Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine. by Bridgeman, A, Roshorm, Y, Lockett, L, Xu, Z, Hopkins, R, Shaw, J, Both, G, Hanke, T

Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges. by Im, E, Hong, J, Roshorm, Y, Bridgeman, A, Létourneau, S, Liljeström, P, Potash, M, Volsky, D, Mcmichael, A, Hanke, T

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1 by Johnson, L, Banerji, S, Lawrance, W, Gileadi, U, Prota, G, Holder, K, Roshorm, Y, Hanke, T, Cerundolo, V, Gale, N, Jackson, D